Latest News and Press Releases
Want to stay updated on the latest news?
-
ORLANDO, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), a technology commercialization platform, today announced it will release its first quarter 2025...
-
LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- Pacvue, the leading commerce acceleration platform that integrates retail media, commerce management and measurement, today announced it is the...
-
~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~ ~ Additional regulatory update and guidance on the Biologics...
-
Accelsius and AeroFlexx started generating revenue with expectations to grow in 2025 ...
-
LOS ANGELES, April 10, 2025 (GLOBE NEWSWIRE) -- CleanTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout climate and clean technology...
-
ORLANDO, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), a differentiated technology commercialization platform, today announced it will release its fourth...
-
ORLANDO, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (Nasdaq: INV) (“Innventure”), a differentiated technology commercialization platform, today announced that Bill Haskell, Chief...
-
ORLANDO, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV), a differentiated technology commercialization platform, today announced key developments for its operating company,...
-
Groundbreaking fMRI study that showed a 21.2% increase in brain blood flow in a Parkinson’s patient after six months of intranasal FGF1 therapy.
-
ORLANDO, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (Nasdaq: INV) (“Innventure”), a technology commercialization platform, today announced it will host a conference call on January 30,...